e-posters
EUROSPINE 2021 VIENNA

Progr. No. P31

Efficacy and Safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional posterolateral lumbar fusion: minimum 1 year follow-up

Category 05. Degenerative (thoracolumbar)
Author Sang Hoon Park
co authors Hee-Jung Son, Sung Hoon Choi, Haewon Jeong, Chang-Nam Kang
Institution Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea
 
Poster
   Click to view poster